Literature DB >> 9464466

Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages.

F Visioli1, S Bellosta, C Galli.   

Abstract

The Mediterranean diet, rich in fresh fruits and vegetables, has been associated with a lower incidence of cardiovascular disease and cancer, partly because of its high proportion of bioactive compounds such as vitamins, flavonoids and polyphenols. The major lipid component of such diet is the drupe-derived olive oil, that can be distinguished from other seed oils for the peculiar composition of its non-triglyceride fraction. In fact, several minor components, including polyphenols, grant the oil its particular taste and aroma. Oleuropein, the most abundant among these components, has been shown to be a potent antioxidant endowed with antiinflammatory properties. We investigated the effects of oleuropein on NO release in cell culture and its activity toward nitric oxide synthase (iNOS) expression. The results show that oleuropein dose-dependently enhance nitrite production in LPS-challenged mouse macrophages. This effect was blocked by the iNOS inhibitor L-NAME, indicating increased iNOS activity. Also, Western blot analysis of cell homogenates show that oleuropein increases iNOS expression in such cells. Taken together, our data suggest that, during endotoxin challenge, oleuropein potentiates the macrophage-mediated response, resulting in higher NO production, currently believed to be beneficial for cellular and organismal protection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464466     DOI: 10.1016/s0024-3205(97)01150-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  32 in total

Review 1.  Antioxidant and other activities of phenolics in olives/olive oil, typical components of the Mediterranean diet.

Authors:  C Galli; F Visioli
Journal:  Lipids       Date:  1999       Impact factor: 1.880

Review 2.  The role of antioxidants in the Mediterranean diet.

Authors:  F Visioli; C Galli
Journal:  Lipids       Date:  2001       Impact factor: 1.880

3.  Antagonism between olive oil phenolics and nitric oxide on lymphomonocyte cytosolic calcium.

Authors:  Carlo A Palmerini; Enrico Carlini; Carla Saccardi; Maurizio Servili; Gianfrancesco Montedoro; Giuseppe Arienti
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

Review 4.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

5.  Localization of the noncovalent binding site between amyloid-beta-peptide and oleuropein using electrospray ionization FT-ICR mass spectrometry.

Authors:  Fotini N Bazoti; Jonas Bergquist; Karin Markides; Anthony Tsarbopoulos
Journal:  J Am Soc Mass Spectrom       Date:  2008-04-08       Impact factor: 3.109

6.  Effects of oleuropein on pentylenetetrazol-induced seizures in mice: involvement of opioidergic and nitrergic systems.

Authors:  Nastaran Rahimi; Bahram Delfan; Nazgol Motamed-Gorji; Ahmad R Dehpour
Journal:  J Nat Med       Date:  2017-01-19       Impact factor: 2.343

7.  Physiological investigations on the effect of olive and rosemary leaves extracts in male rats exposed to thioacetamide.

Authors:  Atef M Al-Attar; Nessreen A Shawush
Journal:  Saudi J Biol Sci       Date:  2014-09-06       Impact factor: 4.219

8.  Methanolic extract of leaves of Jasminum grandiflorum Linn modulates oxidative stress and inflammatory mediators.

Authors:  Adya Prasad Chaturvedi; Yamini Bhusan Tripathi
Journal:  Inflammopharmacology       Date:  2011-06-24       Impact factor: 4.473

Review 9.  Invasive and non-invasive therapies for Alzheimer's disease and other amyloidosis.

Authors:  Gaurav Pandey; Vibin Ramakrishnan
Journal:  Biophys Rev       Date:  2020-09-15

10.  Cardioprotective and neuroprotective roles of oleuropein in olive.

Authors:  Syed Haris Omar
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.